Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 26:10:4759-4771.
doi: 10.2147/CMAR.S179368. eCollection 2018.

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis

Affiliations

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis

Pei Wu et al. Cancer Manag Res. .

Erratum in

Expression of concern in

Abstract

Background: Whether palliative gastrectomy combined with chemotherapy can improve the survival of patients with advanced gastric cancer remains controversial. We performed a meta-analysis to clarify whether palliative gastrectomy plus chemotherapy can benefit patients with incurable advanced gastric cancer and to explore the best candidates in this patient population.

Methods: We searched the literature systematically using electronic databases including PubMed, EMBASE, and the Cochrane Library. And HRs and their 95% CIs were used to express the results for overall survival (OS) and progression-free survival (PFS).

Results: One randomized controlled trial with 175 patients and 12 cohort studies with 2,193 patients were analyzed. The pooled HR for OS (HR=0.43, 95% CI=0.29-0.65, P<0.001), subgroup analysis of stage M1 (HR=0.53, 95% CI=0.40-0.72, P<0.001), peritoneal dissemination (HR=0.46, 95% CI=0.28-0.73, P=0.001), and liver metastasis (HR=0.46, 95% CI=0.33-0.65, P<0.001) all indicated the superiority of palliative gastrectomy plus chemotherapy. However, the pooled HR for PFS (HR=0.61, 95% CI=0.33-1.13, P=0.110) got separate outcome.

Conclusion: The results of this meta-analysis indicated that palliative gastrectomy plus chemotherapy can improve OS for incurable advanced gastric cancer. In addition, analyses based on liver metastasis and peritoneal dissemination demonstrated the advantages of palliative gastrectomy plus chemotherapy. However, the PFS of incurable advanced gastric cancer with palliative gastrectomy plus chemotherapy was no better than that under chemotherapy alone.

Keywords: advanced gastric cancer; chemotherapy; palliative gastrectomy; survival.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow diagram of the identification process for eligible studies.
Figure 2
Figure 2
HR for overall survival Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 3
Figure 3
HR for progression-free survival Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 4
Figure 4
HR for different study Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 5
Figure 5
HR for different race Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 6
Figure 6
HR for M stage of all study Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 7
Figure 7
HR for subgroup M stage of all cohort study in Asian Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 8
Figure 8
HR for peritoneal dissemination Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 9
Figure 9
HR for liver metastasis Notes: S and C: palliative gastrectomy and chemotherapy; C: chemotherapy alone. Abbreviation: SE, standard error.
Figure 10
Figure 10
Test for publication bias. Notes: Based on (A) Begger’s test (p = 0.141) and (B) Egger’s test (p = 0.969), there was no significant publication bias among the articles included.

Similar articles

Cited by

References

    1. Wagner AD, Syn NL, Moehler M, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8:Cd004064. - PMC - PubMed
    1. Thrumurthy SG, Chaudry MA, Chau I, Allum W. Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol. 2015;12(11):676–682. - PubMed
    1. Schlansky B, Sonnenberg A. Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol. 2011;106(11):1978–1985. - PubMed
    1. Ajani JA, Bentrem DJ, National Comprehensive Cancer Network Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11(5):531–546. - PubMed
    1. Japanese GCA, Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2010 (ver. 3) Gastric Cancer. 2011;14(2):113–123. - PubMed